Institutional investors hold a majority ownership of RPRX through the 84.11% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2014, these large investors purchased a net $1.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.5 Million shares of Repros Therapeutics Inc
PAULSON & CO., INC. Bought 1.0 Million shares of Repros Therapeutics Inc